Home

Shared Care


For information We will be working over the coming months to refine and reduce this list to identify which will change into guidelines and which will remain Shared Care Protocols. September 2015

Below you can find prescribing guidelines and their review dates.

Principles of shared care protocols and guidelines

Acromegaly - Review date on publication of NICE guidance

Amiodarone - Review date January 2021

Attention deficit/hyperactivity disorder (ADHD) - June 2022

Azathioprine and Mercaptopurine in adults and young people over 16 years - July 2022

Bipolar disorder - February 2021

Dalteparin - June 2021

Peri-procedural anticoagulation bridging guideline

Dementia - Prescribing of Cognitive Enhancers - April 2022

Denosumab (Prolia ®▼) - October 2022

DMARDs monitoring quick reference guide - February 2022

Please refer to individual shared care guidelines for more detailed information

Epilepsy in adults - February 2021

Epilepsy in children - September 2021

Growth hormone: The treatment of Adults with Growth Hormone (Somatropin) - March 2021

Growth hormone - Treatment of children with recombinant human growth hormone - February 2025

Hydroxycarbamide - To be reviewed and retired July 2020. Note - if prescribing is being directed back to secondary care, please retain hydroxycarbamide as a specialist issued drug within the patients records so you are alerted to drug/disease interactions

Hydroxychloroquine - September 2021

Hypertension – Community Pharmacy Led Hypertension Service - January 2022

Leflunomide - November 2018

Melatonin in the treatment of sleep disorders in children - February 2018

Methotrexate - May 2021

Modafinil – February 2025

Mycophenolate - January 2020

Nebulised Colomycin® and tobramycin in adults with non-cystic fibrosis bronchiectasis - July 2021

Parkinson’s disease - November 2016

Prostatic Cancer - Hormonal Management of Prostatic Cancer – January 2021

Rifaxamin for Hepatic Encephalopathy - January 2020

Riluzole - July 2020